{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T23:50:34Z","timestamp":1783468234140,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.metabol.2004.08.005","type":"journal-article","created":{"date-parts":[[2004,12,15]],"date-time":"2004-12-15T08:15:47Z","timestamp":1103098547000},"page":"49-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Circulating osteoprotegerin levels are associated with age, waist-to-hip ratio, serum total cholesterol, and low-density lipoprotein cholesterol levels in healthy Korean women"],"prefix":"10.1016","volume":"54","author":[{"given":"Eun Sook","family":"Oh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Jung","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Won","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Hyun","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun Ho","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moo Il","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Joo","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheol Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moon Gi","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung Joon","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Woo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2004.08.005_bib1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.metabol.2004.08.005_bib2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/bbrc.1997.6603","article-title":"Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis","volume":"234","author":"Tsuda","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.metabol.2004.08.005_bib3","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1096\/fasebj.12.10.845","article-title":"TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption","volume":"12","author":"Kwon","year":"1998","journal-title":"FASEB J."},{"key":"10.1016\/j.metabol.2004.08.005_bib4","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/01.ATV.0000012303.37971.DA","article-title":"RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function","volume":"22","author":"Schoppet","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.metabol.2004.08.005_bib5","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1210\/endo.142.12.8536","article-title":"Minireview: the OPG\/RANKL\/RANK system","volume":"142","author":"Khosla","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2004.08.005_bib6","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","article-title":"Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification","volume":"12","author":"Bucay","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.metabol.2004.08.005_bib7","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1084\/jem.192.4.463","article-title":"Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis","volume":"192","author":"Min","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.metabol.2004.08.005_bib8","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1161\/hq1001.097102","article-title":"Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D","volume":"21","author":"Price","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.metabol.2004.08.005_bib9","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.1972.03190360019005","article-title":"Calcification of the aorta and osteoporosis. A roentgenographic study","volume":"219","author":"Boukhris","year":"1972","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2004.08.005_bib10","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1161\/01.ATV.20.8.1926","article-title":"Progression of aortic calcification is associated with metacarpal bone loss during menopause: a population-based longitudinal study","volume":"20","author":"Hak","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.metabol.2004.08.005_bib11","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1359\/jbmr.2000.15.10.1974","article-title":"Rate of bone loss is associated with mortality in older women: a prospective study","volume":"15","author":"Kado","year":"2000","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.metabol.2004.08.005_bib12","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1161\/01.CIR.0000031524.49139.29","article-title":"Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease","volume":"106","author":"Jono","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2004.08.005_bib13","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1210\/jc.2002-020775","article-title":"Increased osteoprotegerin serum levels in men with coronary artery disease","volume":"88","author":"Schoppet","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.metabol.2004.08.005_bib14","first-page":"631","article-title":"Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women","volume":"86","author":"Browner","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.metabol.2004.08.005_bib15","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostatic model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentration in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2004.08.005_bib16","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2004.08.005_bib17","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1359\/jbmr.1999.14.4.518","article-title":"Immunological characterization of circulating osteoprotegerin\/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis","volume":"14","author":"Yano","year":"1999","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.metabol.2004.08.005_bib18","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s001980200045","article-title":"Correlates of osteoprotegerin levels in women and men","volume":"13","author":"Khosla","year":"2002","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.metabol.2004.08.005_bib19","first-page":"3162","article-title":"Osteoprotegerin serum levels in men: correlation with age, estrogen, and testosterone status","volume":"86","author":"Szulc","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.metabol.2004.08.005_bib20","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.1210\/jc.2002-020396","article-title":"Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women","volume":"87","author":"Rogers","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.metabol.2004.08.005_bib21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF03179852","article-title":"Interrelationship between serum lipid profile, serum hormones and other components of the metabolic syndrome","volume":"58","author":"Garaulet","year":"2002","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.metabol.2004.08.005_bib22","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1002\/art.11150","article-title":"Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice","volume":"48","author":"Schett","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.metabol.2004.08.005_bib23","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/BF03344054","article-title":"Coagulation and fibrinolysis abnormalities in obesity","volume":"25","author":"De Pergola","year":"2002","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.metabol.2004.08.005_bib24","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/sj.ijo.0802017","article-title":"The central roles of obesity-associated dyslipidaemia, endothelial activation and cytokines in the metabolic syndrome\u2014an analysis by structural equation modelling","volume":"26","author":"Chan","year":"2002","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.metabol.2004.08.005_bib25","doi-asserted-by":"crossref","first-page":"392","DOI":"10.2337\/diacare.24.2.392","article-title":"Control of vascular cell proliferation and migration of PPAR-gamma: a new approach to the macrovascular complications of diabetes","volume":"24","author":"Hsuch","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2004.08.005_bib26","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1172\/JCI10370","article-title":"Peroxisome proliferator-activated receptor-gamma ligands inhibit development of atherosclerosis in LDL-receptor-deficient mice","volume":"106","author":"Li","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.metabol.2004.08.005_bib27","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0006-291X(02)00533-8","article-title":"Activation of peroxisome proliferator-activated receptor gamma inhibits osteoprotegerin gene expression in human aortic smooth muscle cells","volume":"294","author":"Fu","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.metabol.2004.08.005_bib28","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1161\/hq1201.100229","article-title":"Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques","volume":"21","author":"Dhore","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.metabol.2004.08.005_bib29","doi-asserted-by":"crossref","first-page":"20959","DOI":"10.1074\/jbc.C000290200","article-title":"Osteoprotegerin is an alpha vbeta 3-induced, NF-kappa B-dependent survival factor for endothelial cells","volume":"275","author":"Malyankar","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.metabol.2004.08.005_bib30","doi-asserted-by":"crossref","first-page":"20659","DOI":"10.1074\/jbc.M010153200","article-title":"Receptor activator of NF-kappa B and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis","volume":"276","author":"Collin-Osdoby","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.metabol.2004.08.005_bib31","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1091\/mbc.e04-01-0059","volume":"15","author":"Pritzker","year":"2004","journal-title":"Mol. Biol. Cell."},{"key":"10.1016\/j.metabol.2004.08.005_bib32","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1210\/endo.140.9.7131","article-title":"Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells","volume":"140","author":"Hofbauer","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2004.08.005_bib33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2004.08.005_bib34","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Women's Health Initiative Steering Committee: effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial","volume":"291","author":"Anderson","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2004.08.005_bib35","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/0735-1097(96)00014-9","article-title":"27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 1. Pathogenesis of coronary disease: the biologic role of risk factors","volume":"27","author":"Fuster","year":"1996","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049504003233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049504003233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T02:44:49Z","timestamp":1758422689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049504003233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0026049504003233"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2004.08.005","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating osteoprotegerin levels are associated with age, waist-to-hip ratio, serum total cholesterol, and low-density lipoprotein cholesterol levels in healthy Korean women","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2004.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}